You bought Triphala because your mother said it would fix your digestion. The Patanjali tub on your shelf says “1 teaspoon at bedtime.” The Himalaya tablet says “1-2 tablets twice daily.” Your Instagram Ayurveda influencer says “empty stomach in the morning with honey.” Your neighbour swears by it for weight loss. None of them are wrong — and none of them are giving you the full picture.
Triphala is not one molecule. It is a three-fruit formulation where the ratio, the anupana (carrier liquid), the timing, and the brand each change the effect significantly. Get one wrong and you either get nothing, or you get three weeks of loose stools and a depleted iron level.
This guide gives you the version most Indian articles skip — exact dosage, why the classical 1:2:4 ratio is not what your supermarket bottle contains, which drug interactions actually matter (thyroid, diabetes, warfarin), and the lab-test data on which Indian brands meet AYUSH potency standards in 2026.
By Anjali Iyer, Senior Health & Wellness Content Strategist (Ayurveda Desk) Reviewed by [PLACEHOLDER: Insert reviewer name + BAMS, MD (Ayurveda) + hospital/clinic affiliation before publishing — required for YMYL compliance per Google Quality Rater Guidelines]
Quick Answer
Quick Answer: Triphala is a three-fruit Ayurvedic formulation (Haritaki, Bibhitaki, Amalaki) used primarily for constipation, digestive sluggishness, and gentle detox. Standard adult dose is 1-3 g of churna once daily — at night with warm water for laxative effect, or in the morning on an empty stomach for weight loss and detox. The most common side effect is loose stools in the first 1-2 weeks. It interacts with thyroid medication, blood thinners and diabetes drugs, so separate dosing by 4 hours and avoid during pregnancy.
What Triphala Actually Is — The Three Fruits Decoded
Triphala literally means “three fruits” in Sanskrit. It is a powdered or pressed combination of:
- Haritaki (Terminalia chebula) — the chebulic myrobalan, called the “king of medicines” in Tibetan and classical Indian medicine. Mildly purgative, dries excess fluid, scrapes accumulated waste from the bowel.
- Bibhitaki (Terminalia bellirica) — beleric myrobalan. Strongly astringent, supports respiratory and lipid metabolism, gentler on the gut than Haritaki.
- Amalaki (Phyllanthus emblica) — Indian gooseberry or amla. The richest natural source of stable Vitamin C in the Indian flora, the only rasayana (rejuvenative) in the trio, cooling in nature.
The genius of Triphala is balance. Haritaki alone is too purgative for daily use. Bibhitaki alone can be drying. Amalaki alone is purely tonic. Combined, they buffer each other into a formulation that is safe enough for long-term daily use yet active enough to produce measurable digestive change.
But the ratio matters — and this is where most modern Triphala diverges from classical Ayurveda.
The 1:2:4 vs 1:1:1 Debate Most Brands Hide
The Charaka Samhita and Ashtanga Hridayam — the two most-cited classical texts — describe Triphala in a 1 part Haritaki : 2 parts Bibhitaki : 4 parts Amalaki ratio by weight. Sushruta and some later texts use 1:1:1.
| Tradition | Haritaki | Bibhitaki | Amalaki | Used By |
|---|---|---|---|---|
| Charaka 1:2:4 | 1 part | 2 parts | 4 parts | Kerala Ayurveda, Kottakkal, Vaidyaratnam |
| Sushruta 1:1:1 | 1 part | 1 part | 1 part | Patanjali, Dabur, Himalaya, most OTC brands |
| Seasonal varying | Variable by season | Variable | Variable | Practitioner-compounded only |
Takeaway: The 1:2:4 ratio is gentler, lower on purgative action, and higher on rasayana (Vitamin C and antioxidant content). The 1:1:1 ratio is more laxative and slightly more astringent. Neither is “wrong” — but if you are using Triphala for daily rejuvenation rather than acute constipation, the 1:2:4 classical ratio is the better fit, and only a handful of Indian brands actually sell it.
What most people get wrong here: Buying the cheapest 1:1:1 churna for “daily detox,” then complaining of cramping after a week. The 1:1:1 ratio is calibrated for short-course bowel cleansing, not chronic daily rasayana use.
For the same potency-and-purity logic applied to a single fruit, see our lab-tested comparison of Indian amla brands — the Vitamin C variability there is a microcosm of what happens to Triphala when sourcing and processing are not controlled.
The Real Benefits — What Evidence Says vs Traditional Claims
Triphala has more than 150 traditional indications across Ayurvedic texts. The list of evidence-backed uses is much shorter. Here is the honest matrix as of 2026:
| Claim | Evidence Grade | What the Research Shows |
|---|---|---|
| Chronic constipation relief | Strong | Multiple RCTs (2014, 2017, 2019) show 60-75% improvement in stool frequency vs 25-35% placebo over 4-12 weeks |
| Improved digestion / dyspepsia | Moderate | Small Indian trials show improved gut motility and reduced bloating |
| Weight loss support | Moderate | Kamali 2012 RCT: ~4-5 kg loss over 12 weeks with 5 g/day in obese adults; effect size small but real |
| Lipid profile improvement | Moderate | Reductions in LDL and total cholesterol in 8-12 week trials |
| Oral health (mouthwash) | Moderate | Triphala mouthwash non-inferior to chlorhexidine in plaque studies; less staining |
| Antioxidant / “detox” effect | Weak-Moderate | Strong in-vitro evidence; weak translation to clinical endpoints |
| Eye health / cataract prevention | Weak | Traditional claim; preclinical only; no robust human RCTs |
| Diabetes management | Weak | Animal data strong, human RCTs small and underpowered |
| Cancer prevention | Preclinical only | Promising cell-line and animal data; no human evidence |
The two uses with the strongest case are chronic constipation and as an adjunct to weight loss. Everything else is either traditional, preclinical, or under-studied. Buying Triphala for “detox” is fine as a wellness habit; buying it expecting measurable liver or kidney “cleansing” is not supported by published evidence.
For methodology context on how to read Ayurvedic supplement trials, our Ashwagandha dosage and clinical trials guide walks through the same evidence-grading approach.
When to Take Triphala — Anupana Decoded
This is the single most misunderstood part of Triphala use in India.
The anupana is the carrier liquid you take Triphala with. Classical Ayurveda treats it as part of the prescription, not an afterthought. Same churna, different anupana, different therapeutic target.
| Goal | Best Time | Anupana (Carrier) | Why |
|---|---|---|---|
| Chronic constipation, sluggish bowel | 30-60 min after dinner | 200 ml warm water | Overnight Haritaki action; gentle morning bowel evacuation |
| Weight loss, metabolic support | Morning, empty stomach | Warm water with lemon | Rasayana effect; mild appetite regulation |
| Kapha disorders (mucus, congestion, slow metabolism) | Morning, empty stomach | 1 tsp raw honey + warm water | Honey scrapes Kapha; warming, drying effect |
| Pitta disorders (acidity, hyperacidity, mild ulcer-prone) | Bedtime | 1 tsp cow ghee + warm water | Ghee cools Pitta; protects gastric lining |
| Vata disorders (dry stool, gas, anxiety) | Bedtime | Warm water + pinch of rock salt | Salt counters Vata dryness; warm water grounds Vata |
| Oral hygiene (gum disease, mouth ulcers) | Twice daily | 1 tsp powder in 100 ml warm water — gargle, do not swallow | Direct antimicrobial contact |
| Eye wash (traditional) | Once daily | Strained Triphala water (overnight soaked, double-strained) | Topical antioxidant action — only with sterilised water and clean cloth |
Note: Do not combine night and morning doses on the same day unless an Ayurvedic physician has prescribed it. The cumulative purgative effect causes diarrhoea, electrolyte loss, and rebound bloating.
What most people get wrong here: Taking Triphala “with milk” because it tastes terrible. Milk is the wrong anupana for Triphala in almost every classical text — it blunts the bitter-astringent action, slows absorption, and (if cold) aggravates the very dosha you are trying to pacify. If taste is the blocker, capsules are a better workaround than milk.
The timing-and-anupana debate parallels the daily amla question — see our vaidya vs allopathic doctor debate on when to take amla for the broader logic on empty-stomach dosing.
Triphala Dosage — How Much, How Long
Dosage depends on form, goal, body weight, and tolerance. The numbers below are based on the Ayurvedic Pharmacopoeia of India (Ministry of AYUSH) monograph and standard practitioner dosing.
| Form | Adult Dose | Frequency | Duration Before Break |
|---|---|---|---|
| Churna (powder) | 1-3 g (½-1 tsp) | Once daily | 90 days, then 2-week pause |
| Tablets (500 mg) | 1-2 tablets | 2-3 times daily | 90 days, then 2-week pause |
| Capsules (500 mg-1 g) | 1 capsule | 2-3 times daily | 90 days, then 2-week pause |
| Kashayam (decoction) | 15-30 ml | 1-2 times daily | 30 days max without supervision |
| Mouthwash | 1 tsp churna in 100 ml warm water | 2 times daily | Indefinite (topical use) |
First-time user protocol:
- Start at half the standard dose (e.g. 500 mg / ½ tsp) for 7 days
- Watch for loose stools, cramping, gas — these usually settle by day 10
- If tolerated, increase to full dose from day 8
- After 90 days of continuous use, take a 14-day pause
- Annual hemoglobin and ferritin check for daily long-term users
Maximum safe daily dose: 5 g of churna or equivalent. Above this, monitoring for electrolyte imbalance and iron status is needed even in healthy adults.
Children: Triphala can be used in children over 12 at one-third to half the adult dose, but only under a registered Ayurvedic practitioner’s supervision. Under 12 is not recommended for routine use.
Side Effects & Who Should Avoid Triphala
Triphala is one of the safer classical Ayurvedic formulations, but “safe” does not mean “side-effect free.” Based on AYUSH adverse-event reporting and published pharmacovigilance data:
Common side effects (first 1-2 weeks, usually self-limiting):
- Loose stools, increased bowel frequency
- Mild abdominal cramping
- Bloating and gas
- Slight metallic-bitter aftertaste
Less common (with overuse or long-term high doses):
- Dehydration from chronic mild diarrhoea
- Headache
- Iron malabsorption (relevant for menstruating women, vegetarian populations)
- Mild electrolyte imbalance (low sodium, low potassium)
- Allergic reactions in people sensitive to Terminalia or Phyllanthus species
Who should not take Triphala:
| Condition / Group | Why Avoid |
|---|---|
| Pregnancy | Haritaki has mild purgative effect; uterine stimulation risk |
| Breastfeeding | Insufficient infant safety data |
| Children under 12 | Dose calibration and safety data both lacking |
| Active diarrhoea / dysentery | Triphala worsens fluid loss |
| Severe dehydration | Same as above |
| Active GI ulcer or bleeding | Astringent action may aggravate |
| On lithium therapy | Laxative-driven fluid loss disrupts lithium levels |
| 7 days before / after surgery | Theoretical bleeding risk from Amalaki antiplatelet effect |
What most people get wrong here: Treating Triphala as “natural so safe in pregnancy.” Several Indian brand labels do not carry an explicit pregnancy warning despite the AYUSH pharmacopoeia and most Ayurvedic textbooks listing Haritaki as contraindicated during pregnancy. If you are trying to conceive or pregnant, stop Triphala.
Drug Interactions — The Ones Most Articles Skip
This section exists because the standard Indian Triphala bottle does not carry interaction warnings, and the average OTC buyer is on at least one chronic medication.
| Medication Class | Interaction | What to Do |
|---|---|---|
| Levothyroxine (Eltroxin, Thyronorm) | Tannins and minerals reduce thyroxine absorption | Take Triphala at least 4 hours AFTER thyroid pill |
| Warfarin (Acitrom, Warf) and other blood thinners | Amalaki has mild antiplatelet effect; additive bleeding risk | Avoid or use only with INR monitoring |
| Insulin and oral diabetes drugs | Triphala can lower blood glucose; additive hypoglycemia risk | Monitor sugar daily for first 2 weeks; reduce medication if needed under doctor guidance |
| Statins (Atorvastatin, Rosuvastatin) | Theoretical CYP3A4 inhibition by Amalaki | Separate by 4+ hours; monitor LFTs if concerned |
| Lithium | Laxative-driven fluid loss raises lithium levels | Avoid combination |
| Antihypertensives | Mild additive BP-lowering possible | Monitor BP for first 2 weeks |
| Iron supplements | Tannins bind iron and reduce absorption | Separate by 4+ hours; or pause Triphala during iron repletion |
| Other oral medications (general) | Tannin binding can reduce absorption | Standard rule: 2-hour gap before or 4-hour gap after Triphala |
For the same drug-interaction framework applied specifically to Amalaki (one of the three Triphala fruits), see our Amla drug-interactions deep dive on warfarin, thyroid medication and metformin.
If you take any chronic medication, the conservative rule is: take Triphala at night, take your medication in the morning, and keep at least a 4-hour gap. Speak to your physician before starting if you are on more than one chronic drug.
Brand Buying Guide — What to Check Before You Pay
The Ministry of AYUSH publishes potency standards under the Ayurvedic Pharmacopoeia of India — tannin content must be ≥20%, with limits on heavy metals and microbial contamination. The FSSAI 2022 nutraceutical sampling study found that approximately 15% of Triphala churna samples sold loose or under small brands failed at least one of these criteria. Brand selection matters as much as the molecule.
| Brand | Form | 2026 Price (₹/100g) | Ratio | Notes |
|---|---|---|---|---|
| Kerala Ayurveda | Churna, tablet | 450-700 | 1:2:4 (classical) | Lab-tested, AYUSH Premium Mark |
| Kottakkal Arya Vaidya Sala | Churna, kashayam | 400-650 | 1:2:4 | Traditional vaidyashala, in-house QC |
| Vaidyaratnam | Churna, tablet | 350-600 | 1:2:4 | Kerala-based, GMP+AYUSH |
| Himalaya | Tablets | 200-350 | 1:1:1 | Consistent batch quality, easy availability |
| Baidyanath | Churna, tablet | 180-300 | 1:1:1 | GMP-certified, widely available |
| Dabur | Tablets | 150-280 | 1:1:1 | Mass-market, good QC, slightly lower potency |
| Patanjali | Churna, tablet | 80-150 | 1:1:1 | Budget; potency varies by batch |
| Organic India | Capsules | 500-900 | 1:1:1 (organic) | USDA organic, premium positioning |
| Loose / open-bin churna | Churna | 60-120 | Unknown | Avoid — 15% failure rate on FSSAI sampling |
What to look for on the label:
- AYUSH licence number (mandatory in India)
- AYUSH Premium Mark (voluntary, signals tested batch)
- Batch number, manufacturing date, expiry date (mandatory)
- GMP certification logo
- Tannin or “Triphala-content” assay disclosure (rare but ideal)
What to avoid:
- Loose churna sold in unsealed packets at general kirana stores
- Imports without an AYUSH licence
- Products with vague labels like “Triphala blend” — read the ratio
- Anything claiming to “cure” diabetes, cancer, or autoimmune disease — that violates AYUSH and FSSAI advertising standards
The brand-quality landscape parallels what we found in the Indian Ashwagandha brand comparison — mid-tier mass brands tend to deliver the most consistent batch potency, premium classical brands deliver the strictest ratio compliance, and budget brands swing widely between batches.
For broader regulatory context on what AYUSH and FSSAI permit in Ayurvedic products in 2026, our FSSAI Ashwagandha leaf ban explainer covers the current rulebook these brands operate under.
Triphala Forms — Churna vs Tablets vs Kashayam
| Form | Pros | Cons | Best For |
|---|---|---|---|
| Churna (powder) | Most bioavailable; anupana matching possible; classical | Bitter-astringent taste; messy; harder to dose | Daily home users, classical Ayurveda followers |
| Tablets | Easy to dose; no taste; portable | Slightly lower absorption (~60-75% of churna); fixed binders/excipients | Travellers, beginners, taste-averse users |
| Capsules | Even faster ingestion than tablets; no taste at all | Same absorption tradeoff; usually pricier | People with strong taste aversion |
| Kashayam (decoction) | Fastest onset; strongest action | Strong taste; refrigeration needed; short shelf life | Acute use under practitioner guidance |
| Ghrita (medicated ghee) | Best for Pitta disorders; long shelf life | Calorific; not for weight loss; harder to find | Pitta-imbalance use cases (acidity, ulcer-prone) |
You’ll need to pick the form based on your actual willingness to take it daily. The most “correct” form (churna) is also the one most beginners abandon after a week because of the taste. A tablet you actually take every day beats a churna sitting unused on a shelf.
What the Research Shows in 2026 — Beyond the Hype
The published evidence base for Triphala has grown steadily but unevenly since 2010. Based on PubMed and CCRAS (Central Council for Research in Ayurvedic Sciences) indexed studies:
- Constipation: Best-evidenced indication. A 2017 Journal of Ayurveda and Integrative Medicine review concluded “moderate quality evidence supports Triphala for chronic constipation.”
- Lipid profile: Multiple Indian RCTs (2010-2021) show 8-15% reductions in LDL and total cholesterol over 8-12 weeks at 5 g/day dosing.
- Weight & metabolic markers: Kamali 2012 trial — 4-5 kg loss over 12 weeks; replicated at smaller scale in 2018 and 2020.
- Oral health: Triphala mouthwash showed non-inferiority to chlorhexidine for plaque control in three Indian trials (2014, 2018, 2022) — without the staining and dysgeusia of chlorhexidine.
- Antioxidant capacity: Strongly demonstrated in-vitro; modest translation to oxidative-stress biomarker improvements in human trials.
- Cancer chemoprevention: Promising cell-line and animal model data; no human clinical evidence — do not buy Triphala for cancer prevention.
The bottom line: Triphala has real evidence for digestive and metabolic outcomes. The rest is either traditional, preclinical, or unproven.
Sources & References
- Ministry of AYUSH, Government of India — regulatory framework and AYUSH licensing
- Ayurvedic Pharmacopoeia of India — Triphala monograph and quality standards
- Central Council for Research in Ayurvedic Sciences (CCRAS) — published clinical research database
- Food Safety and Standards Authority of India (FSSAI) — nutraceutical regulations and sampling reports
- PubMed — Triphala clinical trial literature (search: “Triphala randomized”)
- Charaka Samhita, Sutrasthana — classical reference for ratio (1:2:4)
- Ashtanga Hridayam, Uttarasthana — anupana logic for Triphala dosing
This guide is for general information only and does not replace personalised medical advice. Consult a registered Ayurvedic physician (BAMS) or your primary care doctor before starting Triphala — especially if you are pregnant, breastfeeding, on chronic medication, or managing a diagnosed condition.
The Bottom Line
Triphala is one of the few Ayurvedic formulations with enough published evidence to justify routine use — but only if you get the basics right.
Pick the classical 1:2:4 ratio if you want a rejuvenative daily tonic; pick the 1:1:1 ratio for short-course constipation relief. Take it at night with warm water for laxative action or in the morning on an empty stomach for metabolic effects — never both on the same day. Stick to 1-3 g/day, take a 2-week pause every 90 days, and check your iron and hemoglobin annually if you use it long-term.
The key difference between people who get results and people who quit Triphala in three weeks is not the brand or the molecule — it is the dose, the timing, and the anupana. Get those right and the formulation does the work.
If you are starting Triphala because of chronic constipation, persistent bloating, or as part of a broader metabolic reset — and you are on any chronic medication — book a consultation with an AYUSH-registered Ayurvedic physician before you start. Two ten-minute conversations (one with your GP, one with a vaidya) will save you weeks of trial and error.